Skip to main content
. 2022 Oct 4;41(2):311–329. doi: 10.5534/wjmh.220091

Table 8. Subgroup analysis of the effects of COVID-19 disease severity on sperm quality and sex hormones.

Variable Subgroup No. p-valuea SMD (95% CI) I2 (%) p-valueb p-valuec
Volume (mL) Mild type 3 0.331 -0.188 (-0.568 to 0.192) 0.0 0.602 0.745
Moderate type 3 0.182 -0.402 (-0.991 to 0.188) 64.0 0.602 0.644
Total sperm count (×106) Mild type 2 0.274 -0.247 (-0.690 to 0.196) 0.0 0.317 -
Moderate type 2 0.161 -0.217 (-0.520 to 0.086) 0.0 0.317 -
Sperm concentration (×106/mL) Mild type 3 0.578 -0.108 (-0.488 to 0.273) 0.0 0.602 0.156
Moderate type 3 0.067 -0.277 (-0.447 to 0.021) 0.0 0.602 0.143
Total motility (%) Mild type 3 0.261 -0.523 (-1.434 to 0.388) 80.4 0.602 0.476
Moderate type 3 0.005 -0.953 (-1.618 to -0.289) 69.1 0.602 0.877
Progressive sperm motility (%) Mild type 3 0.574 -0.205 (-0.918 to 0.508) 69.1 0.602 0.074
Moderate type 3 0.516 -0.309 (-1.242 to 0.624) 89.1 0.317 -

No.: number of studies, SMD: standard mean difference, CI: confidence interval, -: not available.

ap-value of effect. bp-value of Begg’s test for publication bias. cp-value of Egger’s test for publication bias.